Teva Pharmaceutical Industries Ltd

SCHRODER INVESTMENT MANAGEMENT GROUP TEVA

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

7,426,885

Value ($000)

231,793

Weight

0.2%

2013 Q4 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	231,793	0.2%	7,426,885	12/31/2025
2025 Q2	8/13/2025	34,451	0.0%	2,055,568	6/30/2025
2025 Q1	5/13/2025	33,998	0.0%	2,254,502	3/31/2025
2024 Q4	2/12/2025	49,769	0.0%	2,229,786	12/31/2024
2024 Q3	11/13/2024	15,884	0.0%	909,710	9/30/2024
2024 Q2	8/12/2024	16,694	0.0%	1,027,310	6/30/2024
2024 Q1	5/14/2024	12,045	0.0%	853,665	3/31/2024
2023 Q4	2/14/2024	6,343	0.0%	607,589	12/31/2023
2022 Q4	2/10/2023	339	0.0%	37,178	12/31/2022
2022 Q3	11/14/2022	181	0.0%	22,399	9/30/2022
2022 Q2	8/11/2022	3,144	0.0%	395,481	6/30/2022
2022 Q1	5/16/2022	6,653	0.0%	709,326	3/31/2022
2021 Q4	2/14/2022	5,630	0.0%	702,827	12/31/2021
2021 Q3	11/12/2021	7,064	0.0%	725,239	9/30/2021
2021 Q2	8/13/2021	7,160	0.0%	723,270	6/30/2021
2021 Q1	5/28/2021	359	0.0%	31,143	3/31/2021
2020 Q1	5/15/2020	14	0.0%	1,488	3/31/2020
2014 Q1	5/15/2014	212,779	0.2%	4,026,863	3/31/2014
2013 Q4	2/14/2014	182,435	0.2%	4,551,776	12/31/2013